Clinical trial

Simultaneous Integrated Boost (SIB)- IMRT

NCT00389727 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other · Completed

Key facts

NCT number NCT00389727
Title Simultaneous Integrated Boost (SIB)- IMRT
Official title A Dose Escalation Study With Intensity Modulated Radiation Therapy (IMRT) in Moderately Advanced (T2N0, T2N1, T3N0) Squamous Cell Carcinomas (SCC) of the Oropharynx, Larynx and Hypopharynx Using a Simultaneous Integrated Boost (SIB) Approach.
Lead sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other
Collaborators Centre Georges Francois Leclerc
Status Completed
Phase Phase 2
Study type Interventional
Conditions Carcinoma, Squamous Cell
Intervention type Drug
Interventions Radiotherapy
Enrollment 22
Start date Sep 24, 2004
Primary completion May 26, 2008
Completion May 26, 2008
First posted Oct 19, 2006
Last update posted Jul 15, 2019
Countries Belgium

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies